SG178348A1 - Antibodies for the detection of integrin complexes in ffpe material - Google Patents

Antibodies for the detection of integrin complexes in ffpe material Download PDF

Info

Publication number
SG178348A1
SG178348A1 SG2012009254A SG2012009254A SG178348A1 SG 178348 A1 SG178348 A1 SG 178348A1 SG 2012009254 A SG2012009254 A SG 2012009254A SG 2012009254 A SG2012009254 A SG 2012009254A SG 178348 A1 SG178348 A1 SG 178348A1
Authority
SG
Singapore
Prior art keywords
seq
integrin
antibody
antibodies
amino acid
Prior art date
Application number
SG2012009254A
Other languages
English (en)
Inventor
Simon Goodman
Claudia Wilm
Francesc Mitjans
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SG178348A1 publication Critical patent/SG178348A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG2012009254A 2009-08-19 2010-07-15 Antibodies for the detection of integrin complexes in ffpe material SG178348A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09010666 2009-08-19
PCT/EP2010/004313 WO2011020529A2 (en) 2009-08-19 2010-07-15 Antibodies for the detection of integrin complexes in ffpe material

Publications (1)

Publication Number Publication Date
SG178348A1 true SG178348A1 (en) 2012-03-29

Family

ID=42813245

Family Applications (1)

Application Number Title Priority Date Filing Date
SG2012009254A SG178348A1 (en) 2009-08-19 2010-07-15 Antibodies for the detection of integrin complexes in ffpe material

Country Status (17)

Country Link
US (2) US8420348B2 (de)
EP (1) EP2467401B1 (de)
JP (1) JP5734978B2 (de)
KR (1) KR101606236B1 (de)
CN (1) CN102597001B (de)
AU (1) AU2010285265B2 (de)
BR (1) BR112012003686B1 (de)
CA (1) CA2771441C (de)
DK (1) DK2467401T3 (de)
EA (1) EA032728B1 (de)
ES (1) ES2622487T3 (de)
IL (1) IL218119A (de)
MX (1) MX2012001741A (de)
PT (1) PT2467401T (de)
SG (1) SG178348A1 (de)
WO (1) WO2011020529A2 (de)
ZA (1) ZA201201990B (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0911925B8 (pt) 2008-08-05 2024-02-06 Toray Industries Método para detectar um câncer
KR101638490B1 (ko) 2008-08-05 2016-07-11 도레이 카부시키가이샤 암의 치료 및 예방용 의약 조성물
MX340015B (es) 2010-02-04 2016-06-22 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
KR101842893B1 (ko) 2010-02-04 2018-03-28 도레이 카부시키가이샤 암의 치료 및/또는 예방용 의약 조성물
BR112012018943A8 (pt) 2010-02-04 2017-12-19 Toray Industries medicamento e método para o tratamento e/ou prevenção de um câncer
WO2012107211A1 (en) 2011-02-11 2012-08-16 Merck Patent Gmbh Anti-alpha-v integrin antibody for the treatment of prostate cancer
RU2595400C2 (ru) 2011-08-04 2016-08-27 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли
JP6070191B2 (ja) 2011-08-04 2017-02-01 東レ株式会社 癌の治療及び/又は予防用医薬組成物
PT2740793T (pt) 2011-08-04 2018-02-23 Toray Industries Composição de fármacos para o tratamento e/ou a prevenção de cancro
BR112014002616B1 (pt) 2011-08-04 2022-01-18 Toray Industries, Inc Método para detectar câncer pancreático
PT2740794T (pt) 2011-08-04 2018-06-14 Toray Industries Composição farmacêutica para o tratamento e/ou profilaxia de cancro
US9181348B2 (en) 2011-08-04 2015-11-10 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prophylaxis of cancer
KR102041832B1 (ko) 2011-08-04 2019-11-08 도레이 카부시키가이샤 췌장암의 치료 및/또는 예방용 의약 조성물
SG2014014237A (en) * 2011-08-17 2014-07-30 Univ California Antibodies that bind integrin alpha-v beta-8
HUE044611T2 (hu) 2012-02-21 2019-11-28 Toray Industries Gyógyászati készítmény rák kezelésére
US9260513B2 (en) 2012-02-21 2016-02-16 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
BR112014021103A2 (pt) 2012-02-21 2019-10-15 Toray Industries, Inc Anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo
PT2818483T (pt) 2012-02-21 2017-10-09 Toray Industries Composição medicinal para tratamento e/ou prevenção de cancro
KR102155531B1 (ko) 2012-03-30 2020-09-15 도레이 카부시키가이샤 간암의 치료 및/또는 예방용 의약 조성물
PT2832366T (pt) 2012-03-30 2018-01-25 Toray Industries Composição farmacêutica para o tratamento e/ou a prevenção de cancro de vesícula biliar
RU2646466C2 (ru) 2012-07-19 2018-03-05 Торэй Индастриз, Инк. Метод детекции рака
PL2876447T3 (pl) 2012-07-19 2020-05-18 Toray Industries, Inc. Sposób wykrywania nowotworu
TWI707038B (zh) 2013-08-05 2020-10-11 美商扭轉生物科技有限公司 重新合成之基因庫
ES2704909T3 (es) * 2013-08-09 2019-03-20 Toray Industries Composición farmacéutica para el tratamiento y/o la prevención del cáncer
US10351897B2 (en) 2014-02-14 2019-07-16 Bioventures, Llc Acetaminophen adducts and methods of use thereof
WO2016026956A1 (en) * 2014-08-22 2016-02-25 Baxalta GmbH Detection of cho-mif contaminations
EP3009147A1 (de) 2014-10-16 2016-04-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Verfahren zur Behandlung von resistenten Glioblastomen
WO2016090163A2 (en) * 2014-12-03 2016-06-09 Board Of Trustees Of The University Of Arkansas Anti-acetaminophen antibodies and acetaminophen protein adducts
WO2016126882A1 (en) 2015-02-04 2016-08-11 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly
US9981239B2 (en) 2015-04-21 2018-05-29 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis
KR20180050411A (ko) 2015-09-18 2018-05-14 트위스트 바이오사이언스 코포레이션 올리고핵산 변이체 라이브러리 및 그의 합성
KR102794025B1 (ko) 2015-09-22 2025-04-09 트위스트 바이오사이언스 코포레이션 핵산 합성을 위한 가요성 기판
WO2017182834A1 (en) 2016-04-19 2017-10-26 INSERM (Institut National de la Santé et de la Recherche Médicale) New method for treating resistant glioblastoma
US10417457B2 (en) 2016-09-21 2019-09-17 Twist Bioscience Corporation Nucleic acid based data storage
CN110892485B (zh) 2017-02-22 2024-03-22 特韦斯特生物科学公司 基于核酸的数据存储
US10696965B2 (en) 2017-06-12 2020-06-30 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
WO2018231864A1 (en) 2017-06-12 2018-12-20 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
CN111566125A (zh) 2017-09-11 2020-08-21 特韦斯特生物科学公司 Gpcr结合蛋白及其合成
CN111565834B (zh) 2017-10-20 2022-08-26 特韦斯特生物科学公司 用于多核苷酸合成的加热的纳米孔
EP3700932A1 (de) * 2017-10-27 2020-09-02 Kite Pharma, Inc. T-zell-rezeptor-antigen bindende moleküle und verfahren zur verwendung davon
KR102804057B1 (ko) 2018-01-04 2025-05-07 트위스트 바이오사이언스 코포레이션 Dna 기반 디지털 정보 저장
CA3100739A1 (en) 2018-05-18 2019-11-21 Twist Bioscience Corporation Polynucleotides, reagents, and methods for nucleic acid hybridization
US11359024B2 (en) * 2018-09-07 2022-06-14 Pfizer Inc. Anti-AVB8 antibodies and compositions and uses thereof
JP7538798B2 (ja) 2018-12-21 2024-08-22 ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム リン酸化ダイサー抗体およびその使用方法
US12357959B2 (en) 2018-12-26 2025-07-15 Twist Bioscience Corporation Highly accurate de novo polynucleotide synthesis
CN113287013B (zh) * 2019-01-04 2025-04-15 国立大学法人京都大学 溃疡性大肠炎以及原发性硬化性胆管炎的检查方法
CN113766930B (zh) 2019-02-26 2025-07-22 特韦斯特生物科学公司 Glp1受体的变异核酸文库
CA3131691A1 (en) 2019-02-26 2020-09-03 Twist Bioscience Corporation Variant nucleic acid libraries for antibody optimization
AU2020298294A1 (en) 2019-06-21 2022-02-17 Twist Bioscience Corporation Barcode-based nucleic acid sequence assembly
CA3145667A1 (en) * 2019-07-02 2021-01-07 Astute Medical, Inc Antibodies and assays for ccl14
CA3146092A1 (en) * 2019-08-09 2021-02-18 Timothy MYLES Therapeutic antibodies against osteopontin
WO2021061842A1 (en) * 2019-09-23 2021-04-01 Twist Bioscience Corporation Variant nucleic acid libraries for single domain antibodies
JP2022548309A (ja) 2019-09-23 2022-11-17 ツイスト バイオサイエンス コーポレーション Crth2のバリアント核酸ライブラリー
KR20220110231A (ko) * 2019-12-05 2022-08-05 씨젠 인크. 항-αvβ6 항체 및 항체-약물 접합체
IL293670A (en) 2019-12-09 2022-08-01 Twist Bioscience Corp Variable nucleic acid libraries for adenosine receptors
CA3212408A1 (en) * 2021-03-09 2022-09-15 Sachdev S. Sidhu Antibodies against integrin heterodimers and uses thereof
CN114907468B (zh) * 2022-06-10 2023-05-23 东莞理工学院 一种仿刺参整合素多克隆抗体、抗原蛋白及其制备方法
CN116773315A (zh) * 2023-05-07 2023-09-19 中汉(江苏)医学科技有限公司 一种基于免疫组织化学技术的批量化抗体筛选方法
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02502156A (ja) 1987-11-19 1990-07-19 スクリップス クリニック アンド リサーチ ファウンデーション 内皮細胞のrgd指向粘着レセプターに対するモノクローナル抗体
UA58482C2 (uk) * 1994-06-08 2003-08-15 Бьорінгер Інгельхайм Інтернаціональ Гмбх Моноклональне антитіло vff-18 проти сd44v6 і його фрагменти
JPH11512294A (ja) * 1995-09-01 1999-10-26 ラモット ユニヴァーシティー オーソリティ フォア アップライド リサーチ アンド インダストリアル ディヴェロプメント リミテッド 癌の治療、予防および発見を目的とする腫瘍細胞での蛋白ホスファターゼ2C−PP2Cα−発現の操作と検出
WO1999062933A2 (de) 1998-06-02 1999-12-09 Affina Immuntechnik Gmbh Rational designte peptide, ihre herstellung und ihre verwendung
US7163681B2 (en) * 2000-08-07 2007-01-16 Centocor, Inc. Anti-integrin antibodies, compositions, methods and uses
ATE368688T1 (de) 2000-11-08 2007-08-15 Fresenius Medical Care Affina Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
AU2002258518A1 (en) * 2001-03-14 2002-09-24 Millennium Pharmaceuticals, Inc. Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
AU2003217930A1 (en) 2002-03-04 2003-09-22 Medimmune, Llc The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
CN1646160A (zh) 2002-03-13 2005-07-27 拜奥根Idec马萨诸塞公司 抗αvβ6抗体
US20040048312A1 (en) * 2002-04-12 2004-03-11 Ronghao Li Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof
WO2004007530A2 (en) * 2002-07-17 2004-01-22 The Center For Blood Research, Inc. Modified proteins stabilized in a desired conformation and methods for producing same
CN1444043A (zh) * 2002-12-25 2003-09-24 帕弗瑞生物技术(北京)有限公司 一种个体化特异性免疫细胞功能测定方法
SE0301087D0 (sv) * 2003-04-14 2003-04-14 Cartela Ab New monoclonal antibody
US7429487B2 (en) 2005-07-05 2008-09-30 Epitomics, Inc. Fusion partner for production of monoclonal rabbit antibodies
WO2007076927A1 (en) 2005-12-30 2007-07-12 Merck Patent Gmbh Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130
DK2167128T3 (da) 2007-07-17 2012-12-03 Merck Patent Gmbh Fremstillede anti-alfa-v-integrin hybrid-antistoffer

Also Published As

Publication number Publication date
DK2467401T3 (en) 2017-03-20
WO2011020529A3 (en) 2011-06-16
MX2012001741A (es) 2012-03-21
BR112012003686A2 (pt) 2016-03-29
BR112012003686B1 (pt) 2021-09-21
US20130203079A1 (en) 2013-08-08
IL218119A (en) 2015-08-31
AU2010285265A1 (en) 2012-04-05
AU2010285265B2 (en) 2015-05-21
US8420348B2 (en) 2013-04-16
EP2467401A2 (de) 2012-06-27
CN102597001B (zh) 2014-07-30
EP2467401B1 (de) 2017-01-18
WO2011020529A2 (en) 2011-02-24
HK1173455A1 (en) 2013-05-16
JP5734978B2 (ja) 2015-06-17
ZA201201990B (en) 2012-11-28
WO2011020529A8 (en) 2011-04-21
CA2771441A1 (en) 2011-02-24
KR20120059556A (ko) 2012-06-08
JP2013502205A (ja) 2013-01-24
ES2622487T3 (es) 2017-07-06
EA032728B1 (ru) 2019-07-31
PT2467401T (pt) 2017-04-26
US8993261B2 (en) 2015-03-31
US20120171699A1 (en) 2012-07-05
CN102597001A (zh) 2012-07-18
CA2771441C (en) 2016-10-11
IL218119A0 (en) 2012-04-30
EA201200281A1 (ru) 2012-09-28
KR101606236B1 (ko) 2016-03-24
AU2010285265A2 (en) 2012-06-07

Similar Documents

Publication Publication Date Title
AU2010285265B2 (en) Antibodies for the detection of integrin complexes in FFPE material
EP2501724B1 (de) Monoklonale antikörper und diagnostische verwendungen davon
EP2799453B1 (de) Monoklonale ERG2-Antikörper und deren therapeutische Verwendung
JP2021046417A (ja) 抗Aggrusモノクローナル抗体、CLEC−2との結合に必要なAggrusの領域、及びAggrus−CLEC‐2結合阻害剤のスクリーニング方法
CN115667304B (zh) 抗人lag-3抗体及其在免疫组织化学(ihc)中的用途
US10179815B2 (en) Antibodies specifically binding to HER3
TWI782000B (zh) 抗gpr20抗體、其製造方法及其應用
HK1173455B (en) Antibodies for the detection of integrin complexes in ffpe material
CA2118585A1 (en) Characterization of a novel anti-p110rb monoclonal antibody
KR100959020B1 (ko) Tmap/ckap2에 특이적인 단일클론항체
WO2022241212A2 (en) Mertk peptides and uses thereof
JP2023540452A (ja) 抗体を使用した細胞表面mica及びmicbの検出
CN116234823A (zh) 用于在免疫组织化学(ihc)方案中诊断癌症的抗体
CN116635718A (zh) 用于在免疫组织化学(ihc)方案中使用以诊断癌症的抗人cd10抗体
HK40080983A (en) Anti-human lag-3 antibodies and their use in immunohistochemistry (ihc)
KR20210001095A (ko) Pd-l1과 pd-1 간 상호작용 저해제 및 스크리닝 방법
HK1176940B (en) Monoclonal antibodies and diagnostic uses thereof